Infections in bone marrow transplant recipients.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology; D001853:Bone Marrow / Q000276:immunology; D016026:Bone Marrow Transplantation; D002408:Catheters, Indwelling / Q000009:adverse effects; D002690:Chlamydia Infections / Q000209:etiology; D003428:Cross Infection / Q000517:prevention & control; D005334:Fever / Q000209:etiology; D006086:Graft vs Host Disease / Q000209:etiology / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance; D007239:Infections / Q000209:etiology*; D009164:Mycobacterium Infections / Q000209:etiology; D009181:Mycoses / Q000209:etiology; D009503:Neutropenia / Q000209:etiology; D011183:Postoperative Complications; D011528:Protozoan Infections / Q000209:etiology; D011658:Pulmonary Fibrosis / Q000209:etiology; D013203:Staphylococcal Infections / Q000209:etiology; D013997:Time Factors; D014777:Virus Diseases / Q000209:etiology
D000900:Anti-Bacterial Agents